Therapeutic Solutions International, Inc.: key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $99.0K
Net Income/Loss (FY2023): -$2.2M
Total Assets (FY2023): $3.3M
Total Equity (FY2023): $1.3M
Cash Flows from Operating Activities (FY2023): -$1.1M

Source: Therapeutic Solutions International, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

Therapeutic Solutions International, Inc.: key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $99.0K
Net Income/Loss (FY2023): -$2.2M
Total Assets (FY2023): $3.3M
Total Equity (FY2023): $1.3M
Cash Flows from Operating Activities (FY2023): -$1.1M

Source: Therapeutic Solutions International, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.